The Role of Angiotensin II Receptors in Stroke Protection

Level of Systolic Blood Pressure Within the Normal Range and Risk of Recurrent Stroke

(2011) Bruce Ovbiagele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial

(2011) Else Charlotte Sandset et al.   LANCET

Heart Disease and Stroke Statistics—2011 Update

(2010) Véronique L. Roger et al.   CIRCULATION

The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

(2010) Sébastien Czernichow et al.   JOURNAL OF HYPERTENSION

The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease

(2009) John W Wright et al.   JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM

Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors

(2008) Sebastien Faure et al.   JOURNAL OF HYPERTENSION

Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study

(2008) W. Kozak et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial

(2008)   LANCET

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events

(2008) Salim Yusuf et al.   NEW ENGLAND JOURNAL OF MEDICINE